Frakturrisiko nach Therapiestart mit Blutdrucksenkern erhöht

MMW Fortschr Med. 2024 May;166(9):10. doi: 10.1007/s15006-024-3940-1.

[Article in German]

Author

Thomas Müller¹

Affiliation

¹ Springer Medizin, Neu-Isenburg, Deutschland.

PMID: 38755356
DOI: 10.1007/s15006-024-3940-1

No abstract available

Publication types

News

MeSH terms

Aged
Antihypertensive Agents* / adverse effects
Antihypertensive Agents* / therapeutic use
Humans
Hypertension* / drug therapy
Osteoporotic Fractures / prevention & control
Risk Factors